BlackRock’s Atossa Therapeutics ATOS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$700K Sell
133,169
-6
-0% -$38 ﹤0.01% 4443
2025
Q4
$1.18M Hold
133,175
﹤0.01% 4264
2025
Q3
$1.73M Sell
133,175
-10,026
-7% -$124K ﹤0.01% 4141
2025
Q2
$1.78M Sell
143,201
-498,490
-78% -$5.96M ﹤0.01% 4096
2025
Q1
$6.48M Sell
641,691
-8,946
-1% -$109K ﹤0.01% 3526
2024
Q4
$9.21M Buy
650,637
+6,129
+1% +$120K ﹤0.01% 3474
2024
Q3
$14.7M Buy
644,508
+31,372
+5% +$633K ﹤0.01% 3215
2024
Q2
$10.9M Buy
613,136
+429,718
+234% +$9.51M ﹤0.01% 3339
2024
Q1
$4.95M Sell
183,418
-3,011
-2% -$48.4K ﹤0.01% 3676
2023
Q4
$2.46M Sell
186,429
-6,005
-3% -$64.8K ﹤0.01% 3961
2023
Q3
$2.13M Sell
192,434
-797
-0.4% -$11.6K ﹤0.01% 3968
2023
Q2
$3.65M Sell
193,231
-20,404
-10% -$247K ﹤0.01% 3836
2023
Q1
$2.32M Sell
213,635
-17,151
-7% -$191K ﹤0.01% 3984
2022
Q4
$1.83M Sell
230,786
-4,872
-2% -$55.9K ﹤0.01% 4174
2022
Q3
$2.95M Sell
235,658
-3,588
-1% -$52.1K ﹤0.01% 3997
2022
Q2
$3.91M Sell
239,246
-389,890
-62% -$6.14M ﹤0.01% 3932
2022
Q1
$11.8M Sell
629,136
-6,837
-1% -$139K ﹤0.01% 3486
2021
Q4
$15.3M Sell
635,973
-736
-0.1% -$26.9K ﹤0.01% 3428
2021
Q3
$31.1M Buy
636,709
+39,756
+7% +$2.31M ﹤0.01% 2979
2021
Q2
$56.6M Buy
596,953
+494,801
+484% +$26.2M ﹤0.01% 2613
2021
Q1
$3.23M Buy
102,152
+102,107
+226,904% +$3.73M ﹤0.01% 4132
2020
Q4
$1K Hold
45
﹤0.01% 5005
2020
Q3
$1K Hold
45
﹤0.01% 4967
2020
Q2
$2K Hold
45
﹤0.01% 4895
2020
Q1
$1K Hold
45
﹤0.01% 4878
2019
Q4
$1K Hold
45
﹤0.01% 4904
2019
Q3
$1K Hold
45
﹤0.01% 4898
2019
Q2
$2K Hold
45
﹤0.01% 4898
2019
Q1
$2K Hold
45
﹤0.01% 4815
2018
Q4
$1K Hold
45
﹤0.01% 4860
2018
Q3
$1K Hold
45
﹤0.01% 4919
2018
Q2
$1K Hold
45
﹤0.01% 4936
2018
Q1
$3K Hold
45
﹤0.01% 4765
2017
Q4
$2K Hold
45
﹤0.01% 4798
2017
Q3
$4K Hold
45
﹤0.01% 4757
2017
Q2
$4K Hold
45
﹤0.01% 4811
2017
Q1
$6K Buy
+45
New +$11.5K ﹤0.01% 4769

Other funds holding ATOS